Anika Therapeutics, Inc. (ANIK)
15.14
+0.02
(+0.13%)
USD |
NASDAQ |
May 07, 16:00
15.14
0.00 (0.00%)
Pre-Market: 20:00
Anika Therapeutics Total Liabilities (Quarterly) : 45.49M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| TELA Bio, Inc. | 75.71M |
| BioCryst Pharmaceuticals, Inc. | -- |
| Masimo Corp. | 853.80M |
| Lantheus Holdings, Inc. | 1.138B |
| Evolus, Inc. | 249.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.39M |
| Shareholders Equity (Quarterly) | 133.90M |
| Debt to Equity Ratio | 0.1922 |
| Current Ratio | 4.462 |
| Net Debt Paydown Yield | 0.02% |